Skip to content

Frontlight ResearchEarly access

Institution

Hospital CUF Descobertas

Lisbon, PortugalWebsite

7running trials
6closed trials
1,343publications (OpenAlex)

Running trials

Recruiting
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
NCT07589634· Phase 2· Janssen Research & Development, LLC· Source
Recruiting
Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063.
NCT07904052· Phase 3· Inmunotek S.L.· Source
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
NCT06472245· Phase 3· OSE Immunotherapeutics· Source
Active, not recruiting
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus
NCT05531565· Phase 2/3· Biogen· Source
Recruiting
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
NCT04892173· Phase 3· Johnson & Johnson Enterprise Innovation Inc.· Source
Active, not recruiting
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
NCT05060016· Phase 2· Amgen· Source
Recruiting
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
NCT02834884· European Organisation for Research and Treatment of Cancer - EORTC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Asthma1 recruiting
Childhood cancers1 recruiting
Head and neck cancer1 recruiting
Lung cancer1 recruiting
Multiple myeloma1 recruiting

Closed trials

Completed
A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)
NCT05651711· Phase 3· Amgen· Source
Terminated
Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma
NCT04854499· Phase 2· Gilead Sciences· Source
Completed
A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer
NCT04148911· Phase 3· Hoffmann-La Roche· Source
Completed
A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)
NCT04085172· Phase 4· Shire· Source
Completed
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
NCT03232073· Phase 3· Actelion· Source
Completed
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
NCT03104400· Phase 3· AbbVie· Source

Registry name variants (15)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Hospital CUF Descobertas
Lisbon, 1998-018
9 trials
Hosp. Cuf Descobertas
Lisbon, 1998-018
3 trials
Hospital CUF Descobertas /ID# 165866
Lisbon, 1998-018
1 trial
- NCT03104400A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)
CUF Descobertas Hospital /ID# 263188
Lisbon, Lisbon District 1998-018
Hospital CUF Descobertas /ID# 160539
Lisbon, 1998-018
Hospital CUF Descobertas /ID# 205431
Lisbon, 1998-018
Hospital CUF Descobertas /ID# 245702
Lisbon, 1998-018
Hospital CUF Descobertas /ID# 254323
Lisbon, 1998-018
Hospital CUF Descobertas /ID# 257419
Lisbon, 1998-018
Hospital CUF Descobertas /ID# 259788
Lisbon, 1998-018
Hospital CUF Descobertas, Lisbon, Cadiology Department
Lisbon, 1998-018
Hospital CUF Descobertas (Site 0706)
Lisbon, 1998-018
Hospital CUF Descobertas (Site 0953)
Lisbon, 1998-018
Hospital CUF Descobertas (Site 1815)
Lisbon, Lisbon District 1998-018
Hospital CUF Descobertas (Site 2006)
Lisbon, Lisbon District 1998-018

Conditions

Diseases this institution publishes on or runs trials for.

Chronic spontaneous urticaria6 works · 0 trials

Institution data: ROR 05gsnx339 (CC0-1.0)Updated 14 Nov 2026

Report an error